These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23438801)

  • 1. Pharmacodynamic evaluation and physical/chemical analysis of two formulations of propofol used in target-controlled infusion.
    Simoni RF; de Paula Gomes Miziara LE; Esteves LO; Ribeiro D'Castro JG; Morales CA; Esqueapatti Sandrin CE; Contente TC; Oliveira-Silva D
    Braz J Anesthesiol; 2013; 63(1):59-65. PubMed ID: 23438801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic evaluation and physical/chemical analysis of two formulations of propofol used in target-controlled infusion.
    Simoni RF; Miziara LE; Esteves LO; D'Castro JG; Morales CA; Sandrin CE; Contente TC; Oliveira-Silva D
    Braz J Anesthesiol; 2013 Jan; 63(1):59-65. PubMed ID: 24565090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacodynamics of two different propofol formulations].
    Ihmsen H; Jeleazcov C; Schüttler J; Schwilden H; Bremer F
    Anaesthesist; 2006 Jun; 55(6):635-42. PubMed ID: 16479409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion.
    Kim KM; Choi BM; Park SW; Lee SH; Christensen LV; Zhou J; Yoo BH; Shin HW; Bae KS; Kern SE; Kang SH; Noh GJ
    Anesthesiology; 2007 May; 106(5):924-34. PubMed ID: 17457123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accuracy of target-controlled infusion (TCI) with 2 different propofol formulations].
    Ihmsen H; Jeleazcov C; Schüttler J; Schwilden H; Bremer F
    Anaesthesist; 2004 Oct; 53(10):937-43. PubMed ID: 15372176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics and pharmacokinetics of propofol in a medium-chain triglyceride emulsion.
    Ward DS; Norton JR; Guivarc'h PH; Litman RS; Bailey PL
    Anesthesiology; 2002 Dec; 97(6):1401-8. PubMed ID: 12459665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacodynamic effects of a lower-lipid emulsion of propofol: a comparison with the standard propofol emulsion.
    Song D; Hamza M; White PF; Klein K; Recart A; Khodaparast O
    Anesth Analg; 2004 Mar; 98(3):687-91, table of contents. PubMed ID: 14980920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining Target-Controlled Infusion: An Assessment of Pharmacodynamic Target-Controlled Infusion of Propofol and Remifentanil Using a Response Surface Model of Their Combined Effects on Bispectral Index.
    Short TG; Hannam JA; Laurent S; Campbell D; Misur M; Merry AF; Tam YH
    Anesth Analg; 2016 Jan; 122(1):90-7. PubMed ID: 26683103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.
    Calvo R; Telletxea S; Leal N; Aguilera L; Suarez E; De La Fuente L; Martin-Suarez A; Lukas JC
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1038-48. PubMed ID: 15315624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics and pharmacodynamics of propofol in a modified cyclodextrin formulation (Captisol) versus propofol in a lipid formulation (Diprivan): an electroencephalographic and hemodynamic study in a porcine model.
    Egan TD; Kern SE; Johnson KB; Pace NL
    Anesth Analg; 2003 Jul; 97(1):72-9, table of contents. PubMed ID: 12818946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol.
    Cox EH; Knibbe CA; Koster VS; Langemeijer MW; Tukker EE; Lange R; Kuks PF; Langemeijer HJ; Lie-A-Huen L; Danhof M
    Pharm Res; 1998 Mar; 15(3):442-8. PubMed ID: 9563075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between depth of anesthesia and effect-site concentration of propofol during induction with the target-controlled infusion technique in elderly patients.
    Liu SH; Wei W; Ding GN; Ke JD; Hong FX; Tian M
    Chin Med J (Engl); 2009 Apr; 122(8):935-40. PubMed ID: 19493418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the potency of different propofol formulations: a randomized, double-blind trial using closed-loop administration.
    Le Guen M; Grassin-Delyle S; Cornet C; Genty A; Chazot T; Dardelle D; Liu N; Dreyfus JF; Mazoit JX; Devillier P; Alvarez JC; Sessler DI; Fischler M
    Anesthesiology; 2014 Feb; 120(2):355-64. PubMed ID: 24051391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection.
    Knibbe CA; Voortman HJ; Aarts LP; Kuks PF; Lange R; Langemeijer HJ; Danhof M
    Br J Clin Pharmacol; 1999 Jun; 47(6):653-60. PubMed ID: 10383543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical properties and stability of two emulsion formulations of propofol.
    Han J; Davis SS; Washington C
    Int J Pharm; 2001 Mar; 215(1-2):207-20. PubMed ID: 11250106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two propofol formulations are equivalent in small children aged 1 month to 3 years.
    Pessenbacher K; Gutmann A; Eggenreich U; Gschanes A; Rehak P; List WF
    Acta Anaesthesiol Scand; 2002 Mar; 46(3):257-63. PubMed ID: 11939915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of propofol 6% SAZN versus propofol 1% SAZN and Diprivan-10 for short-term sedation following coronary artery bypass surgery.
    Knibbe CA; Aarts LP; Kuks PF; Voortman HJ; Lie-A-Huen L; Bras LJ; Danhof M
    Eur J Clin Pharmacol; 2000 Apr; 56(1):89-95. PubMed ID: 10853884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different loading doses of dexmedetomidine on bispectral index under stepwise propofol target-controlled infusion.
    Wang T; Ge S; Xiong W; Zhou P; Cang J; Xue Z
    Pharmacology; 2013; 91(1-2):1-6. PubMed ID: 23095710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion.
    Fechner J; Ihmsen H; Hatterscheid D; Jeleazcov C; Schiessl C; Vornov JJ; Schwilden H; Schüttler J
    Anesthesiology; 2004 Sep; 101(3):626-39. PubMed ID: 15329587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reevaluation of the time course of the effect of propofol described with the Schnider pharmacokinetic model].
    Sepúlveda PO; Mora X
    Rev Esp Anestesiol Reanim; 2012 Dec; 59(10):542-8. PubMed ID: 23040653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.